Pure Global

German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany - Trial NCT05438069

Access comprehensive clinical trial information for NCT05438069 through Pure Global AI's free database. This phase not specified trial is sponsored by Jena University Hospital and is currently Recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05438069
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT05438069
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany

Study Focus

Hypercholesterolemia

Observational

Sponsor & Location

Jena University Hospital

Jena, Germany

Timeline & Enrollment

N/A

Dec 11, 2020

Dec 11, 2025

500 participants

Primary Outcome

LDL-C change

Summary

The German Inclisiran Network is a registry of patients with hypercholesterinemia on
 treatment with the siRNA inclisiran in Germany

ICD-10 Classifications

Pure hypercholesterolaemia
Lipoprotein deficiency
Hyperglycaemia, unspecified
Disorders of lipoprotein metabolism and other lipidaemias
Other disorders of lipoprotein metabolism

Data Source

ClinicalTrials.gov

NCT05438069

Non-Device Trial